Jack Fuller

Jack Fuller

Auto-generated profile, based on publicly available information

Jack Fuller

University of Leeds, United Kingdom

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
FCFrank W. Charlton
Frank W. Charlton
SHSamantha Hover
Samantha Hover
JFJack Fuller
Jack Fuller
RHRoger Hewson
Roger Hewson
Juan FontanaJuan Fontana
Juan Fontana
Jamel MankouriJamel Mankouri
Jamel Mankouri
The Bunyavirales order of segmented negative-sense RNA viruses includes > 500 isolates that infect insects, animals, and plants and are often associated with severe and fatal disease in humans. To multiply and cause disease, bunyaviruses must translocate their genomes from outside the cell into the cytosol, achieved by transit through the endocytic network. We have previously shown that the model bunyaviruses Bunyamwera virus (BUNV) and Hazara virus (HAZV) exploit the changing potassium concentration ([K+]) of maturing endosomes to release their genomes at the appropriate endosomal location. K+ was identified as a biochemical cue to activate the viral fusion machinery, promoting fusion between viral and cellular membranes, consequently permitting genome release. In this study, we further define the biochemical prerequisites for BUNV and HAZV entry and their K+ dependence. Using drug–mediated cholesterol extraction along with viral-entry and K+ uptake assays, we report three major findings: (1) BUNV and HAZV require cellular cholesterol during endosomal escape; (2) cholesterol depletion from host cells impairs K+ accumulation in maturing endosomes, revealing new insights into endosomal K+ homeostasis; and (3) “priming” BUNV and HAZV virions with K+ before infection alleviates their cholesterol requirement. Taken together, our findings suggest a model in which cholesterol abundance influences endosomal K+ levels and consequently the efficiency of bunyavirus infection. The ability to inhibit bunyaviruses with existing cholesterol-lowering drugs may offer new options for future antiviral interventions for pathogenic bunyaviruses.